Bell Investment Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bell Investment Advisors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-36	Closed	-$3K	–	2045
2022 Q2	$3K	Buy	+36	New	+$1.6K	﹤0.01%	1065
2021 Q4	$3K	Buy	72 +53	+279%	+$2.37K	﹤0.01%	1068
2021 Q3	$1K	Buy	+19	New	+$1.35K	﹤0.01%	1679

Bell Investment Advisors's TPTX Position: Q3 2022 in Review

Bell Investment Advisors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 36 shares — an estimated $3K sold.

Bell Investment Advisors first reported a position in TPTX in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Bell Investment Advisors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Bell Investment Advisors sold 36 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $3K.
Bell Investment Advisors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Bell Investment Advisors's Turning Point Therapeutics, Inc. Common Stock position peaked at $3K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Bell Investment Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.